Article

Epikeratome earns European approval

Atlanta-CIBA Vision Corp. has received CE Mark approval to market its Centurion SES EpiEdge epikeratome for use in Epi-LASIK procedures.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
Related Content
Atia Vision receives go-ahead from FDA to begin clinical study of the OmniVu Lens System
May 23rd 2025

Atia Vision receives go-ahead from FDA to begin clinical study of the OmniVu Lens System

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Genentech’s Susvimo receives new FDA indication for diabetic retinopathy
May 22nd 2025

Genentech’s Susvimo receives new FDA indication for diabetic retinopathy

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED
May 22nd 2025

FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED

Diffuse-trickling FAF pattern linked to greater ellipsoidal zone loss in GA
May 22nd 2025

Diffuse-trickling FAF pattern linked to greater ellipsoidal zone loss in GA

© 2025 MJH Life Sciences

All rights reserved.